<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02655211</url>
  </required_header>
  <id_info>
    <org_study_id>13-0735</org_study_id>
    <nct_id>NCT02655211</nct_id>
  </id_info>
  <brief_title>Laser Induced Bioengineered Remodeling of Thermally Injured Skin Trial</brief_title>
  <acronym>LIBERTI</acronym>
  <official_title>Laser Induced Bioengineered Remodeling of Thermally Injured Skin Trial: The Sequential Multiple Assignment Randomized Trial (SMART) Approach to Treatment of Hypertrophic Burn Scars</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the efficacy of pulsed dye laser (PDL) and carbon dioxide (CO2)&#xD;
      laser in conjunction with usual care (MED) for the treatment of hypertrophic burn scars and&#xD;
      will determine the optimal sequence and timing of lasers and usual care.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigator will compare usual care (MED), which will be offered to all patients, to two&#xD;
      types of laser treatment (PDL and CO2), which the investigators hypothesize to be beneficial.&#xD;
      The timing and sequence of therapy will be randomized, but all patients will receive some&#xD;
      form of laser treatment. If the investigators simply stopped at the end of Aim 1, the&#xD;
      investigators would complete a traditional randomized control trial (RCT), with some patients&#xD;
      potentially receiving laser treatment. However, the investigators are interested in&#xD;
      determining whether the sequence of laser treatments is beneficial; therefore, the&#xD;
      investigators will be employing a sequential multiple assignment randomized trial (SMART)&#xD;
      design. Because of the nature of the study and SMART design, the investigators will offer all&#xD;
      patients some form of laser therapy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Due to staff shortages we are closing the study.&#xD;
  </why_stopped>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Hypotrophic scar score on the Vancouver Scar Scale (VSS) from baseline to three month visit</measure>
    <time_frame>Baseline and 3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Long-term hypotrophic scar score on VSS</measure>
    <time_frame>Two years</time_frame>
  </secondary_outcome>
  <number_of_arms>12</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Hypertrophic Scars</condition>
  <arm_group>
    <arm_group_label>CO2-CO2-Med</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive two blocks of CO2 laser treatment, followed by one block of usual care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Med-CO2-CO2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive one block of usual care, followed by two blocks of CO2 laser therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CO2-Med-CO2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive one block of CO2 laser therapy, one block of usual care, and finally one more block of CO2 laser therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PDL-PDL-MED</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive two blocks of PDL laser therapy, followed by one block of usual care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Med-PDL-PDL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive one block of usual care, followed by two blocks of PDL laser therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PDL-Med-PDL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive one block of PDL laser therapy, followed by one block of usual care, followed by one block of PDL laser therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PDL-CO2-Med</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive one block of PDL laser therapy, followed by one block of CO2 laser therapy, followed by one block of usual care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CO2-PDL-Med</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive one block of CO2 laser therapy, followed by one block of PDL laser therapy, followed by one block of usual care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Med-PDL-CO2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive one block of usual care, followed by one block of PDL laser therapy, followed by one block of CO2 laser therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Med-CO2-PDL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive one block of usual care, followed by one block of CO2 laser therapy, followed by one block of PDL laser therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PDL-Med-CO2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive one block of PDL laser therapy, followed by one block of usual care, followed by one block of CO2 laser therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CO2-Med-PDL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive one block of CO2 laser therapy, followed by one block of usual care, followed by one block of PDL laser therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CO2 laser treatment</intervention_name>
    <description>Surgical treatment using fractionated ablative carbon dioxide laser (CO2)</description>
    <arm_group_label>CO2-CO2-Med</arm_group_label>
    <arm_group_label>CO2-Med-CO2</arm_group_label>
    <arm_group_label>CO2-Med-PDL</arm_group_label>
    <arm_group_label>CO2-PDL-Med</arm_group_label>
    <arm_group_label>Med-CO2-CO2</arm_group_label>
    <arm_group_label>Med-CO2-PDL</arm_group_label>
    <arm_group_label>Med-PDL-CO2</arm_group_label>
    <arm_group_label>PDL-CO2-Med</arm_group_label>
    <arm_group_label>PDL-Med-CO2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PDL laser treatment</intervention_name>
    <description>Surgical treatment using flashlamp-excited pulsed dye laser (PDL)</description>
    <arm_group_label>CO2-Med-PDL</arm_group_label>
    <arm_group_label>CO2-PDL-Med</arm_group_label>
    <arm_group_label>Med-CO2-PDL</arm_group_label>
    <arm_group_label>Med-PDL-CO2</arm_group_label>
    <arm_group_label>Med-PDL-PDL</arm_group_label>
    <arm_group_label>PDL-CO2-Med</arm_group_label>
    <arm_group_label>PDL-Med-CO2</arm_group_label>
    <arm_group_label>PDL-Med-PDL</arm_group_label>
    <arm_group_label>PDL-PDL-MED</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual care</intervention_name>
    <description>Usual care (i.e., non-surgical) therapy (compression garments, massage, physical therapy, silicone gel sheeting)</description>
    <arm_group_label>CO2-CO2-Med</arm_group_label>
    <arm_group_label>CO2-Med-CO2</arm_group_label>
    <arm_group_label>CO2-Med-PDL</arm_group_label>
    <arm_group_label>CO2-PDL-Med</arm_group_label>
    <arm_group_label>Med-CO2-CO2</arm_group_label>
    <arm_group_label>Med-CO2-PDL</arm_group_label>
    <arm_group_label>Med-PDL-CO2</arm_group_label>
    <arm_group_label>Med-PDL-PDL</arm_group_label>
    <arm_group_label>PDL-CO2-Med</arm_group_label>
    <arm_group_label>PDL-Med-CO2</arm_group_label>
    <arm_group_label>PDL-Med-PDL</arm_group_label>
    <arm_group_label>PDL-PDL-MED</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  have a burn injury which will be at least 6 months old at the time of first treatment,&#xD;
&#xD;
          -  have one or more symptomatic burn scars (with at least one or more symptoms such as&#xD;
             erythema, pruritus, surface irregularity, or tightness not caused by a contracture&#xD;
             that would be better served with surgical treatment),&#xD;
&#xD;
          -  desire laser treatment,&#xD;
&#xD;
          -  be at least 6 months of age at the time of treatment,&#xD;
&#xD;
          -  agree to have no aesthetic treatments for their burn scars, such as peels or fillers,&#xD;
             until they have completed the study (two-year period),&#xD;
&#xD;
          -  agree to be randomized into one of the study's treatment conditions,&#xD;
&#xD;
          -  agree to return for all treatment and follow-up visits for the two-year study period,&#xD;
&#xD;
          -  agree to refrain from participating in any other treatment-oriented clinical trial for&#xD;
             the duration of this study, and&#xD;
&#xD;
          -  be able and willing to follow the protocol requirements.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  be women who are pregnant or planning to become pregnant during the study,&#xD;
&#xD;
          -  have had any previous laser treatment of their burn scars,&#xD;
&#xD;
          -  have open wounds that are not re-epithelialized in the areas of proposed study&#xD;
             treatment,&#xD;
&#xD;
          -  be taking systemic steroids or immunosuppression medication,&#xD;
&#xD;
          -  have a connective tissue disorder,&#xD;
&#xD;
          -  be receiving or planning to receive chemotherapy or radiation during the study,&#xD;
&#xD;
          -  be medically unable to tolerate anesthesia, or&#xD;
&#xD;
          -  have other conditions that in the opinion of the investigators or clinicians may&#xD;
             affect participant safety or compromise study objectives.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Scott Hultman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UNC-Chapel Hill</affiliation>
  </overall_official>
  <verification_date>April 2017</verification_date>
  <study_first_submitted>November 12, 2014</study_first_submitted>
  <study_first_submitted_qc>January 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2016</study_first_posted>
  <last_update_submitted>April 13, 2017</last_update_submitted>
  <last_update_submitted_qc>April 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertrophy</mesh_term>
    <mesh_term>Cicatrix, Hypertrophic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

